SG11201901160TA - Reduction of leachable beta-glucan levels from cellulose-containing filter materials - Google Patents

Reduction of leachable beta-glucan levels from cellulose-containing filter materials

Info

Publication number
SG11201901160TA
SG11201901160TA SG11201901160TA SG11201901160TA SG11201901160TA SG 11201901160T A SG11201901160T A SG 11201901160TA SG 11201901160T A SG11201901160T A SG 11201901160TA SG 11201901160T A SG11201901160T A SG 11201901160TA SG 11201901160T A SG11201901160T A SG 11201901160TA
Authority
SG
Singapore
Prior art keywords
burlington
international
emd millipore
massachussetts
cellulose
Prior art date
Application number
SG11201901160TA
Inventor
Akshat Gupta
Dana Kinzlmaier
Kara Pizzelli
Elizabeth Goodrich
Original Assignee
Emd Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emd Millipore Corp filed Critical Emd Millipore Corp
Publication of SG11201901160TA publication Critical patent/SG11201901160TA/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D39/00—Filtering material for liquid or gaseous fluids
    • B01D39/14—Other self-supporting filtering material ; Other filtering material
    • B01D39/16—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres
    • B01D39/18—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres the material being cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D37/00—Processes of filtration
    • B01D37/02—Precoating the filter medium; Addition of filter aids to the liquid being filtered
    • B01D37/025—Precoating the filter medium; Addition of filter aids to the liquid being filtered additives incorporated in the filter
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/08—Polysaccharides
    • B01D71/10—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M37/00—Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination
    • C12M37/02—Filters
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21C—PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
    • D21C9/00—After-treatment of cellulose pulp, e.g. of wood pulp, or cotton linters ; Treatment of dilute or dewatered pulp or process improvement taking place after obtaining the raw cellulosic material and not provided for elsewhere
    • D21C9/001—Modification of pulp properties
    • D21C9/002—Modification of pulp properties by chemical means; preparation of dewatered pulp, e.g. in sheet or bulk form, containing special additives
    • D21C9/004—Modification of pulp properties by chemical means; preparation of dewatered pulp, e.g. in sheet or bulk form, containing special additives inorganic compounds
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21C—PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
    • D21C9/00—After-treatment of cellulose pulp, e.g. of wood pulp, or cotton linters ; Treatment of dilute or dewatered pulp or process improvement taking place after obtaining the raw cellulosic material and not provided for elsewhere
    • D21C9/001—Modification of pulp properties
    • D21C9/002—Modification of pulp properties by chemical means; preparation of dewatered pulp, e.g. in sheet or bulk form, containing special additives
    • D21C9/005—Modification of pulp properties by chemical means; preparation of dewatered pulp, e.g. in sheet or bulk form, containing special additives organic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/10—Filtering material manufacturing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2273/00—Operation of filters specially adapted for separating dispersed particles from gases or vapours
    • B01D2273/18—Testing of filters, filter elements, sealings

Abstract

DepthFilter Filtrate collected on Load Cells DAQ Data Collection Ismatec Pump FIG. 1 Pressure transducers (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 03 May 2018 (03.05.2018) WIP0 I PCT Iiiimmoimiolollmonoloommoiloacionomom oimIE (10) International Publication Number WO 2018/080999 Al (51) International Patent Classification: BOLD 39/18 (2006.01) (21) International Application Number: PCT/US2017/057878 (22) International Filing Date: 23 October 2017 (23.10.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/413,013 26 October 2016 (26.10.2016) US (71) Applicant: EMD MILLIPORE CORPORATION [US/US]; 400 Summit Drive, Burlington, Massachussetts 01803 (US). (72) Inventors: GUPTA, Akshat; c/o EMD Millipore Corpora- tion, 400 Summit Drive, Burlington, Massachussetts 01803 (US). KINZLMATER, Dana; c/o EMD Millipore Cor- poration, 400 Summit Drive, Burlington, Massachussetts 01803 (US). PIZZELLI, Kara; c/o EMD Millipore Cor- poration, 400 Summit Drive, Burlington, Massachussetts 01803 (US). GOODRICH, Elizabeth; c/o EMD Millipore Corporation, 400 Summit Drive, Burlington, Massachus- setts 01803 (US). (74) Agent: SODEY, Benjamin, J. et al.; EMD Millipore Cor- poration, 400 Summit Drive, Burlington, Massachussetts 01803 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). (54) Title: REDUCTION OF LEACHABLE BETA-GLUCAN LEVELS FROM CELLULOSE-CONTAINING FILTER = MATERIALS 1-1 O 00 O Flushing buffer/Feed Streams on Stir Plates O (57) : Treatment methods for reduction of (1—>3)13-D-glucan leachables from cellulose- containing filter materials are de- C scribed. [Continued on next page] WO 2018/080999 Al MIDEDIMOMOIDEIREEMOTENHOHOHOMEMOIS Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h))
SG11201901160TA 2016-10-26 2017-10-23 Reduction of leachable beta-glucan levels from cellulose-containing filter materials SG11201901160TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662413013P 2016-10-26 2016-10-26
PCT/US2017/057878 WO2018080999A1 (en) 2016-10-26 2017-10-23 Reduction of leachable beta-glucan levels from cellulose-containing filter materials

Publications (1)

Publication Number Publication Date
SG11201901160TA true SG11201901160TA (en) 2019-03-28

Family

ID=60421840

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201901160TA SG11201901160TA (en) 2016-10-26 2017-10-23 Reduction of leachable beta-glucan levels from cellulose-containing filter materials

Country Status (9)

Country Link
US (3) US11014031B2 (en)
EP (2) EP3851178A1 (en)
JP (3) JP6941168B2 (en)
KR (3) KR20230003256A (en)
CN (1) CN109789355B (en)
DK (1) DK3532186T3 (en)
ES (1) ES2858432T3 (en)
SG (1) SG11201901160TA (en)
WO (1) WO2018080999A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11014031B2 (en) 2016-10-26 2021-05-25 Emd Millipore Corporation Reduction of leachable beta-glucan levels from cellulose-containing filter materials

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL25654C (en) * 1926-12-01
US2207076A (en) * 1938-11-30 1940-07-09 Hercules Powder Co Ltd Method for the purification of cellulose ethers
NL65516C (en) * 1943-05-25
US3580841A (en) * 1969-07-31 1971-05-25 Us Interior Ultrathin semipermeable membrane
JPS4926944B1 (en) * 1970-12-30 1974-07-13
AU553707B2 (en) 1982-04-27 1986-07-24 Borden (Uk) Limited Impregnated filter paper
NZ208241A (en) 1984-05-22 1987-09-30 John Stephen Ayers Purification of blood plasma or serum: selective removal of (very) low density lipoproteins (ldl and vldl)
US4606824A (en) * 1984-10-26 1986-08-19 Chaokang Chu Modified cellulose separation matrix
US4830885A (en) * 1987-06-08 1989-05-16 Allied-Signal Inc. Chlorine-resistant semipermeable membranes
US5150723A (en) 1988-09-28 1992-09-29 Eastman Kodak Company Process for the production of tobacco smoke filters
US5085784A (en) * 1989-04-07 1992-02-04 Cuno, Incorporated Use of cationic charge modified filter media
US5114537A (en) * 1990-10-23 1992-05-19 Bio Associates, A California Partnership Dry sheet-like filtering material for liquid depth filtration
US5098569A (en) * 1990-12-13 1992-03-24 Monsanto Company Surface-modified support membrane and process therefor
JPH11243939A (en) 1998-02-27 1999-09-14 Japan Tobacco Inc Filter for tobacco product
DE10346256B3 (en) * 2003-09-24 2004-10-21 E. Begerow Gmbh & Co Production of filter material, especially deep filter layer, with predetermined number of natural fibers, e.g. cellulose, includes adding specific enzyme to suspension to convert each toxic polysaccharide to nontoxic or less toxic product
US20050247419A1 (en) * 2004-05-06 2005-11-10 Hamed Othman A Treatment composition for making acquisition fluff pulp in sheet form
US7337782B2 (en) 2004-08-18 2008-03-04 R.J. Reynolds Tobacco Company Process to remove protein and other biomolecules from tobacco extract or slurry
JP2007014854A (en) * 2005-07-06 2007-01-25 Kawamura Inst Of Chem Res Filtration filter, manufacturing method of filtration filter, and hemofiltration method
JP2007307513A (en) * 2006-05-22 2007-11-29 Asahi Kasei Medical Co Ltd Pretreatment method of cellulosic filter
CN101172164A (en) * 2006-11-03 2008-05-07 中国科学院化学研究所 Biopolymer nano tunica fibrosa material capable of being biological degraded and absorbed, preparing method and uses of the same
JP2008274525A (en) * 2007-04-06 2008-11-13 Asahi Kasei Corp Nonwoven cellulose fabric having low basis weight
CN104744605A (en) * 2007-11-13 2015-07-01 卡吉尔公司 Process For The Preparation Of Purified Beta-(1,3)-d-glucans
EP2226171B1 (en) * 2007-12-21 2019-04-10 Mitsubishi Chemical Corporation Fiber composite
EP3006934B1 (en) * 2008-08-01 2017-02-01 BioVentures, Inc., Device for the purification, isolation, desalting or buffer/solvent exchange of substances
WO2011093510A1 (en) 2010-02-01 2011-08-04 三菱化学株式会社 Method for producing cellulose-fiber flat structure
JP2013106520A (en) 2010-03-15 2013-06-06 Japan Tobacco Inc Non-heating type tobacco
US20150068978A1 (en) * 2012-03-15 2015-03-12 Advanced Mem-Tch Ltd. Enhancment of membrane robustness by treatment with ionic materials
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
KR20160020524A (en) * 2013-07-19 2016-02-23 아사히 가세이 셍이 가부시키가이샤 Fine cellulose fiber sheet
US11014031B2 (en) * 2016-10-26 2021-05-25 Emd Millipore Corporation Reduction of leachable beta-glucan levels from cellulose-containing filter materials

Also Published As

Publication number Publication date
DK3532186T3 (en) 2021-01-04
JP2019531892A (en) 2019-11-07
US11014031B2 (en) 2021-05-25
JP2021154280A (en) 2021-10-07
US20230321574A1 (en) 2023-10-12
EP3532186B1 (en) 2020-12-09
US20190224600A1 (en) 2019-07-25
US20210236973A1 (en) 2021-08-05
CN109789355A (en) 2019-05-21
CN109789355B (en) 2021-09-21
EP3851178A1 (en) 2021-07-21
WO2018080999A1 (en) 2018-05-03
EP3532186A1 (en) 2019-09-04
KR20230003256A (en) 2023-01-05
JP7387674B2 (en) 2023-11-28
KR20190055193A (en) 2019-05-22
JP6941168B2 (en) 2021-09-29
JP2023159171A (en) 2023-10-31
KR20210131440A (en) 2021-11-02
ES2858432T3 (en) 2021-09-30
WO2018080999A8 (en) 2019-01-31
KR102622770B1 (en) 2024-01-10
US11712647B2 (en) 2023-08-01

Similar Documents

Publication Publication Date Title
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201805320XA (en) Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degeneration
SG11201903454VA (en) Immunologically discernible cell surface variants for use in cell therapy
SG11201810600WA (en) Fxr (nr1h4) modulating compounds
SG11201903636PA (en) Acoustic wave filter including two types of acoustic wave resonators
SG11201908088RA (en) Antibodies against pd-l1
SG11201908567UA (en) Modified cyclic dinucleotide compounds
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201811048UA (en) Single-cell transcript sequencing
SG11201808990QA (en) Compositions for topical application of compounds
SG11201909011PA (en) Niraparib compositions
SG11201807998WA (en) Treatment Of Inflammatory Diseases With Inhibitors Of C5a Activity
SG11201811232XA (en) Treatment of amd using aav2 variant with aflibercept
SG11201407774XA (en) Conversion of biomass
SG11201809530PA (en) Method for recovery of phosphate
SG11201811251RA (en) Multi-chamber deposition equipment for solid free form fabrication
SG11201904535VA (en) Prevention and treatment of bone and cartilage damage or disease
SG11201807827VA (en) Process for the preparation of pegylated drug-linkers and intermediates thereof
SG11201808713YA (en) Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
SG11201900283YA (en) Codeword disabling in multi-subframe grants
SG11201407800SA (en) Selective binding of biological targets to solid phase ureides
SG11201903329WA (en) Method for preparing electrocompetent yeast cells, and method for using said cells
SG11201907774VA (en) Sulfoximine glycosidase inhibitors
SG11201908325PA (en) Process for the preparation of glucuronide drug-linkers and intermediates thereof
SG11201808525UA (en) Anti-complement factor bb antibodies and uses thereof